Buscar
Mostrando ítems 31-40 de 1225
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design
(2014)
Human respiratory syncytial virus (hRSV) is the leading cause of respiratory illness in infants and young children around the globe. This pathogen, which was discovered in 1956, continues to cause a huge number of ...
New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus
(2016)
The respiratory syncytial virus (RSV) is the most prevalent etiological agent of lower respiratory tract infections and the first cause of hospitalization in infants due to respiratory disease worldwide. However, efforts ...
A Recombinant Bacillus Calmette-Guérin (BCG) vaccine promotes protective humoral immunity against the human respiratory syncytial virus
(2015)
Human respiratory syncytial virus (hRSV) is the leading cause of hospitalizations due to acute respiratory tract infections in children
younger than two years. HRSV causes a wide variety of symptoms, which are associated ...
Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
(2021)
Respiratory infections are among the major public health burdens, especially during winter. Along these lines, the human respiratory syncytial virus (hRSV) is the principal viral agent causing acute lower respiratory tract ...
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection
(2017)
Human Respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are the two major etiological viral agents of lower respiratory tract diseases, affecting mainly infants, young children and the elderly. Although ...
Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis
(2014)
Human Respiratory Syncytial Virus (hRSV) is the leading cause of lower respiratory tract diseases, affecting particularly newborns and young children. This virus is able to modulate the immune response, generating a ...
Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis
(2014)
Human Respiratory Syncytial Virus (hRSV) is the leading cause of lower respiratory tract diseases, affecting particularly newborns and young children. This virus is able to modulate the immune response, generating a ...
Addressing the public health burden of respiratory viruses: the battle against respiratory viruses (BRaVe) initiative
(Future Medicine, 2013)
Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical ...
Addressing the public health burden of respiratory viruses: the battle against respiratory viruses (BRaVe) initiative
(Future Medicine, 2013)
Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical ...